Amello Jason 4
4 · Candel Therapeutics, Inc. · Filed Sep 23, 2022
Insider Transaction Report
Form 4
Amello Jason
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-09-21+230,000→ 230,000 totalExercise: $3.21Exp: 2032-09-21→ Common Stock (230,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest and become exercisable on September 21, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.